FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2899003303> ?p ?o ?g. }

• W2899003303 endingPage "87" @default.
• W2899003303 startingPage "79" @default.
• W2899003303 abstract "Abstract Background Primary aldosteronism (PA) may confer increased cardiovascular risk beyond effects on systemic blood pressure, but contributing mechanisms remain incompletely understood. We compared plasma (apo)lipoproteins and lipoprotein particle characteristics, GlycA, a pro‐inflammatory glycoprotein biomarker of enhanced chronic inflammation, and plasma total branched‐chain amino acids (BCAA), measured using nuclear magnetic resonance (NMR) spectroscopy, between patients with PA, control subjects without hypertension, subjects with untreated hypertension and subjects with treated hypertension. Methods Twenty PA patients were individually matched with 2819 control subjects without hypertension, 501 subjects with untreated hypertension and 878 subjects with treated hypertension participating in the PREVEND (Prevention of Renal and Vascular End‐Stage Disease) cohort study with respect to age, sex, body mass index, smoking and statin use. The Vantera® Clinical Analyzer was used to determine NMR‐based laboratory parameters. Results Total cholesterol, low‐density lipoprotein cholesterol (LDL‐C), high‐density lipoprotein cholesterol (HDL‐C), apolipoprotein (apo) B, apolipoprotein A‐I (apoA‐I), LDL particle and HDL particle concentrations were all decreased in PA subjects vs control subjects and subjects with untreated hypertension ( P < 0.016). Triglycerides (TG) and triglyceride‐rich lipoprotein (TRL) concentrations were lower in PA subjects vs subjects with (untreated) hypertension. GlycA was increased in PA vs the three comparator groups ( P < 0.016). Total BCAA concentrations were unaltered in PA. Conclusions Primary aldosteronism is associated with lower concentrations of LDL and HDL particles and to some extent also with lower TG and TRL particle concentrations. PA is also characterized by increased GlycA levels, indicating enhanced low‐grade chronic inflammation. Low HDL particle concentrations and increased GlycA could contribute to accelerated cardiovascular disease development in PA." @default.
• W2899003303 created "2018-11-09" @default.
• W2899003303 creator A5005538765 @default.
• W2899003303 creator A5033537869 @default.
• W2899003303 creator A5038949732 @default.
• W2899003303 creator A5041851398 @default.
• W2899003303 creator A5041910578 @default.
• W2899003303 creator A5046217753 @default.
• W2899003303 creator A5062003423 @default.
• W2899003303 creator A5090455680 @default.
• W2899003303 date "2018-11-20" @default.
• W2899003303 modified "2023-09-26" @default.
• W2899003303 title "Primary aldosteronism is associated with decreased low-density and high-density lipoprotein particle concentrations and increased GlycA, a pro-inflammatory glycoprotein biomarker" @default.
• W2899003303 cites W1965343609 @default.
• W2899003303 cites W1984875752 @default.
• W2899003303 cites W2002364623 @default.
• W2899003303 cites W2022393522 @default.
• W2899003303 cites W2023229626 @default.
• W2899003303 cites W2023797086 @default.
• W2899003303 cites W2024222798 @default.
• W2899003303 cites W2026387613 @default.
• W2899003303 cites W2032582841 @default.
• W2899003303 cites W2033995962 @default.
• W2899003303 cites W2044923750 @default.
• W2899003303 cites W2053867069 @default.
• W2899003303 cites W2054950948 @default.
• W2899003303 cites W2060552707 @default.
• W2899003303 cites W2092831846 @default.
• W2899003303 cites W2099583783 @default.
• W2899003303 cites W2104230242 @default.
• W2899003303 cites W2104342488 @default.
• W2899003303 cites W2105927411 @default.
• W2899003303 cites W2107999636 @default.
• W2899003303 cites W2110446902 @default.
• W2899003303 cites W2113014870 @default.
• W2899003303 cites W2114856643 @default.
• W2899003303 cites W2115819915 @default.
• W2899003303 cites W2116087989 @default.
• W2899003303 cites W2118625269 @default.
• W2899003303 cites W2124037655 @default.
• W2899003303 cites W2128996388 @default.
• W2899003303 cites W2133346314 @default.
• W2899003303 cites W2153879939 @default.
• W2899003303 cites W2156497356 @default.
• W2899003303 cites W2156822292 @default.
• W2899003303 cites W2188916344 @default.
• W2899003303 cites W2193856342 @default.
• W2899003303 cites W2199065014 @default.
• W2899003303 cites W2210755862 @default.
• W2899003303 cites W2265212715 @default.
• W2899003303 cites W2279972281 @default.
• W2899003303 cites W2328127416 @default.
• W2899003303 cites W2337792773 @default.
• W2899003303 cites W2383172913 @default.
• W2899003303 cites W2387913746 @default.
• W2899003303 cites W2406364591 @default.
• W2899003303 cites W2427069358 @default.
• W2899003303 cites W2431305192 @default.
• W2899003303 cites W2442064385 @default.
• W2899003303 cites W2539494034 @default.
• W2899003303 cites W2586627670 @default.
• W2899003303 cites W2591751159 @default.
• W2899003303 cites W2604185895 @default.
• W2899003303 cites W2618047617 @default.
• W2899003303 cites W2633114018 @default.
• W2899003303 cites W2768057265 @default.
• W2899003303 cites W2784218801 @default.
• W2899003303 cites W2792334910 @default.
• W2899003303 cites W2795852751 @default.
• W2899003303 doi "https://doi.org/10.1111/cen.13891" @default.
• W2899003303 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30372543" @default.
• W2899003303 hasPublicationYear "2018" @default.
• W2899003303 type Work @default.
• W2899003303 sameAs 2899003303 @default.
• W2899003303 citedByCount "13" @default.
• W2899003303 countsByYear W28990033032019 @default.
• W2899003303 countsByYear W28990033032020 @default.
• W2899003303 countsByYear W28990033032021 @default.
• W2899003303 countsByYear W28990033032022 @default.
• W2899003303 countsByYear W28990033032023 @default.
• W2899003303 crossrefType "journal-article" @default.
• W2899003303 hasAuthorship W2899003303A5005538765 @default.
• W2899003303 hasAuthorship W2899003303A5033537869 @default.
• W2899003303 hasAuthorship W2899003303A5038949732 @default.
• W2899003303 hasAuthorship W2899003303A5041851398 @default.
• W2899003303 hasAuthorship W2899003303A5041910578 @default.
• W2899003303 hasAuthorship W2899003303A5046217753 @default.
• W2899003303 hasAuthorship W2899003303A5062003423 @default.
• W2899003303 hasAuthorship W2899003303A5090455680 @default.
• W2899003303 hasBestOaLocation W28990033031 @default.
• W2899003303 hasConcept C126322002 @default.
• W2899003303 hasConcept C134018914 @default.
• W2899003303 hasConcept C185592680 @default.
• W2899003303 hasConcept C2778163477 @default.
• W2899003303 hasConcept C2778913445 @default.
• W2899003303 hasConcept C2780072125 @default.
• W2899003303 hasConcept C2780221984 @default.
• W2899003303 hasConcept C2780233176 @default.

• next